All

Results: 53653-53664 of 72593

PR Newswire associated0

Supermicro Unveils New X14 AI, Rackmount, Multi-Node, and Edge Server Families Based on Intel® Xeon® 6 Processors with E-cores and Soon, P-cores Systems With Liquid Cooling

PR Newswire associated0

Tackling MVNO Challenges: IPLOOK Showcases its Future-Proof Solutions at MVNOs World Congress 2024

Anonymity Order granted to Claimant Jennifer Baccanello set aside in sexual harassment action against Hong Kong lawyer, Stefano Mariani

ACCESSWIRE associated0

DynaResource, Inc. Announces Executive Leadership Change

Hitachi and Microsoft Enter Milestone Agreement to Accelerate Business and Social Innovation with Generative AI

Rio Tinto to develop BioIron™ R&D facility in Western Australia to test low-carbon steelmaking

PR Newswire associated0

Built by Nature Prize Awards €500,000 to Biobased Construction Innovators

Carnival Corporation to Strategically Align Portfolio and Absorb P&O Cruises Australia into Carnival Cruise Line

Tide partners with Connect Earth to help SMEs reach Net Zero

PR Newswire associated0

Westport and Volvo Group Announce Closing of the Joint Venture

Professor Dean Fennell, principal investigator, presents results from the Phase 1 MITOPE clinical study of a first-in-human, and potential first-in-class therapeutic, RSO-021. (Photo: Business Wire)

RS Oncology Announces Positive Data from a Phase 1 Clinical Trial of RSO-021, a First-in-Class Therapeutic for Malignant Pleural Mesothelioma

PR Newswire associated0

Jamie Carsey named Chief Claims Officer, Markel Specialty